These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9682004)

  • 1. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice.
    Baumgart DC; Olivier WA; Reya T; Peritt D; Rombeau JL; Carding SR
    Cell Immunol; 1998 Jul; 187(1):52-66. PubMed ID: 9682004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
    Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
    Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ cytotoxic T cells induce relapsing colitis in normal mice.
    Nancey S; Holvöet S; Graber I; Joubert G; Philippe D; Martin S; Nicolas JF; Desreumaux P; Flourié B; Kaiserlian D
    Gastroenterology; 2006 Aug; 131(2):485-96. PubMed ID: 16890603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice.
    Mizoguchi E; Mizoguchi A; Bhan AK
    Lab Invest; 1997 Mar; 76(3):385-97. PubMed ID: 9121121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
    Higgins LM; McDonald SA; Whittle N; Crockett N; Shields JG; MacDonald TT
    J Immunol; 1999 Jan; 162(1):486-93. PubMed ID: 9886424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
    Matsumoto S; Nagaoka M; Hara T; Kimura-Takagi I; Mistuyama K; Ueyama S
    Clin Exp Immunol; 2004 Jun; 136(3):432-9. PubMed ID: 15147344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel large granular lymphocyte-like cell isolated from IL-2-supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation.
    Hörnqvist E; Enerbäck L; Chen XJ; Lycke N
    Cell Immunol; 1993 Apr; 148(1):71-90. PubMed ID: 8495492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 protects intestinal epithelial cells.
    Obermeier F; Hausmann M; Kellermeier S; Kiessling S; Strauch UG; Duitman E; Bulfone-Paus S; Herfarth H; Bock J; Dunger N; Stoeck M; Schölmerich J; Falk W; Rogler G
    Eur J Immunol; 2006 Oct; 36(10):2691-9. PubMed ID: 16981178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice.
    Lúdvíksson BR; Strober W; Nishikomori R; Hasan SK; Ehrhardt RO
    J Immunol; 1999 Apr; 162(8):4975-82. PubMed ID: 10202045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
    Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
    Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis.
    Drakes ML; Blanchard TG; Czinn SJ
    J Leukoc Biol; 2005 Dec; 78(6):1291-300. PubMed ID: 16204624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.
    Panwala CM; Jones JC; Viney JL
    J Immunol; 1998 Nov; 161(10):5733-44. PubMed ID: 9820555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.